Announcements
Projects
Orgs
Project Post
Articles 187
Votes 2
0% interested
The Lancet

Authors 1

The Lancet
The potential epidemiologic, clinical, and economic value of a universal coronavirus vaccine: a modelling study - The Lancet
>1y
Long-term outcomes following hospital admission for COVID-19 versus seasonal influenza: a cohort study - The Lancet
>1y
3-year outcomes of discharged survivors of COVID-19 following the SARS-CoV-2 omicron (B.1.1.529) wave in 2022 in China: a longitudinal cohort study - The Lancet
>1y
Effectiveness of BNT162b2 BA.4/5 bivalent mRNA vaccine against a range of COVID-19 outcomes in a large health system in the USA: a test-negative case–control study - The Lancet
>1y
Atezolizumab plus bevacizumab versus active surveillance in patients with resected or ablated high-risk hepatocellular carcinoma (IMbrave050): a randomised, open-label, multicentre, phase 3 trial - The Lancet
>1y
Blood-based tests for multicancer early detection (PATHFINDER): a prospective cohort study - The Lancet
almost2y
Multiorgan MRI findings after hospitalisation with COVID-19 in the UK (C-MORE): a prospective, multicentre, observational cohort study - The Lancet
almost2y
Artificial intelligence for breast cancer detection in screening mammography in Sweden: a prospective, population-based, paired-reader, non-inferiority study - The Lancet
almost2y
Venous insufficiency and acrocyanosis in long COVID: dysautonomia - The Lancet
almost2y
Association between particulate matter (PM)2·5 air pollution and clinical antibiotic resistance: a global analysis - The Lancet
almost2y
Rebooting cancer screening with artificial intelligence - The Lancet
almost2y
The risk of sexual transmission of HIV in individuals with low-level HIV viraemia: a systematic review - The Lancet
almost2y
Stereotactic ablative radiotherapy with or without immunotherapy for early-stage or isolated lung parenchymal recurrent node-negative non-small-cell lung cancer: an open-label, randomised, phase 2 trial - The Lancet
almost2y
Hearing intervention versus health education control to reduce cognitive decline in older adults with hearing loss in the USA (ACHIEVE): a multicentre, randomised controlled trial - The Lancet
almost2y
Viral persistence in children infected with SARS-CoV-2: current evidence and future research strategies - The Lancet
~2y
Retatrutide, a GIP, GLP-1 and glucagon receptor agonist, for people with type 2 diabetes: a randomised, double-blind, placebo and active-controlled, parallel-group, phase 2 trial conducted in the USA - The Lancet
~2y
Diabetes: a defining disease of the 21st century - The Lancet
~2y
Association between hearing aid use and all-cause and cause-specific dementia: an analysis of the UK Biobank cohort - The Lancet
>2y
Effectiveness of a bivalent mRNA vaccine booster dose to prevent severe COVID-19 outcomes: a retrospective cohort study - The Lancet
>2y
Risk factors and vectors for SARS-CoV-2 household transmission: a prospective, longitudinal cohort study - The Lancet
>2y
Long-term COVID-19 booster effectiveness by infection history and clinical vulnerability and immune imprinting: a retrospective population-based cohort study - The Lancet
>2y
SARS-CoV-2 omicron (B.1.1.529)-related COVID-19 sequelae in vaccinated and unvaccinated patients with cancer: results from the OnCovid registry - The Lancet
>2y
Early childhood lower respiratory tract infection and premature adult death from respiratory disease in Great Britain: a national birth cohort study - The Lancet
>2y
Rajat Khosla: shifting power structures in global health - The Lancet
>2y
Celebration of 200 years - The Lancet
>2y